trial

Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies

NCTId NCT00937716
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 75 (actual)
Sponsored by University of Alabama at Birmingham
Primary completion 2020-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
75 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2008-10
Primary completion
2020-12-31
Eligibility
ALL · 19 Years · 55 Years

Interventions & indications

Drugs
—

Sponsors

University of Alabama at BirminghamLead Sponsor

Investigators

1
Adrienne C. Lahti, MDPrincipal Investigator

Sites

1 total
Birmingham, United States

Facts & assertions

4 sourced
Enrollment
75
Phase
NA
Primary Completion Date
2020-12-31
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
University of Alabama at Birmingham
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Adrienne C. Lahti, MD
person